Petros Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 355%.

Top 20 shareholders own 7.84% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.7%	Juggernaut Management, LLC	570,355	US$154.3k	0%	no data
0.44%	UBS Asset Management AG	44,221	US$12.0k	0%	no data
0.37%	Geode Capital Management, LLC	37,517	US$10.1k	23.5%	no data
0.32%	Two Sigma Securities, LLC, Asset Management Arm	32,284	US$8.7k	-40.1%	no data
0.32%	The Vanguard Group, Inc.	31,811	US$8.6k	0%	no data
0.16%	BlackRock, Inc.	16,128	US$4.4k	-2.31%	no data
0.12%	Intracoastal Capital LLC	12,042	US$3.3k	0%	no data
0.11%	Joshua Silverman	11,238	US$3.0k	0%	no data
0.083%	Bruce Bernstein	8,347	US$2.3k	0%	no data
0.083%	Wayne Walker	8,315	US$2.2k	0%	no data
0.083%	Gregory Bradley	8,315	US$2.2k	0%	no data
0.033%	Tower Research Capital Europe Limited	3,255	US$880.4	-0.58%	no data
0.01%	EMFO, LLC	1,000	US$270.6	0%	no data
0.0031%	National Bank Investments Inc.	313	US$84.8	0%	no data
0.002%	Osaic Wealth, Inc. , Asset Management Arm	200	US$54.2	0%	no data
0.0012%	Mitchell Arnold	117	US$31.7	0%	no data
0.00079%	Group One Trading LP, Asset Management Arm	79	US$21.4	0%	no data
0.00072%	Bank of America Corporation, Asset Management Arm	72	US$19.5	33.3%	no data
0.00019%	Morgan Stanley, Investment Banking and Brokerage Investments	19	US$5.1	0%	no data
0.00014%	Securities America Advisors, Inc.	14	US$3.8	0%	no data